Advertisement

Uveitis pp 199-209 | Cite as

Diagnostic Biopsy in Uveitis

  • Jaya B. Kumar
  • Sumit Sharma
Chapter
First Online:
Part of the Current Practices in Ophthalmology book series (CUPROP)

Abstract

Elucidating the cause of uveitis is critical to evaluate for systemic disease and to determine treatment and prognosis. The diagnosis of various forms of uveitis is typically determined by a multitude of factors including patient history, clinical manifestations, course of uveitis, imaging, laboratory testing, and response to treatment. Unfortunately, most patients do not present with classic clinical findings and the underlying etiology is a diagnostic dilemma. While serologic diagnosis is limited to a few entities (such as syphilis), the diagnostic yield of systemic diagnostic testing for many infectious and malignant processes can be quite low. Obtaining a sample of aqueous, vitreous, or chorioretinal tissue can help make the diagnosis and guide therapy when there is suspicion for malignancy, infection, or inflammation that fails to respond to medical therapy.

Keywords

Diagnostic vitrectomy Chorioretinal biopsy Infectious uveitis Noninfectious uveitis 
This is a preview of subscription content, log in to check access.

References

  1. 1.
    Yu HG, Kim TW. Diagnostic and therapeutic vitrectomy for uveitis. In: APWC S, Hinton DR, Sadda SR, Wiedemann P, editors. Ryan’s retina. Part 1, Section 5. New York: Elsevier; 2018.Google Scholar
  2. 2.
    Rhoades WR, Baldwin AJ, Nguyen QD, Do DV. Vitreous, retinal, and choroidal biopsy. In: Schachat APWC, Hinton DR, Sadda SR, Wiedemann P, editors. Ryan’s retina. Part 1, Section 5. New York: Elsevier; 2018. p. 2296–308.Google Scholar
  3. 3.
    Thomas AS, Flaxel CJ. Vitreoretinal surgery in uveitis. Int Ophthalmol Clin. 2015;55(2):67–79.CrossRefGoogle Scholar
  4. 4.
    Park SS, D’Amico DJ, Foster CS. The role of invasive diagnostic testing in inflammatory eye diseases. Int Ophthalmol Clin. 1994;34(3):229–38.CrossRefGoogle Scholar
  5. 5.
    Hunter RS, Lobo AM. Current diagnostic approaches to infectious anterior uveitis. Int Ophthalmol Clin. 2011;51(4):145–56.CrossRefGoogle Scholar
  6. 6.
    Harper TW, Miller D, Schiffman JC, Davis JL. Polymerase chain reaction analysis of aqueous and vitreous specimens in the diagnosis of posterior segment infectious uveitis. Am J Ophthalmol. 2009;147(1):140–7, e2.CrossRefGoogle Scholar
  7. 7.
    Farhadi A, Haniloo A, Fazaeli A, Moradian S, Farhadi M. PCR-based diagnosis of toxoplasma parasite in ocular infections having clinical indications of toxoplasmosis. Iran J Parasitol. 2017;12(1):56–62.PubMedPubMedCentralGoogle Scholar
  8. 8.
    Montoya JG, Parmley S, Liesenfeld O, Jaffe GJ, Remington JS. Use of the polymerase chain reaction for diagnosis of ocular toxoplasmosis. Ophthalmology. 1999;106(8):1554–63.CrossRefGoogle Scholar
  9. 9.
    de Boer JH, Verhagen C, Bruinenberg M, Rothova A, de Jong PT, Baarsma GS, et al. Serologic and polymerase chain reaction analysis of intraocular fluids in the diagnosis of infectious uveitis. Am J Ophthalmol. 1996;121(6):650–8.CrossRefGoogle Scholar
  10. 10.
    Sjoholm-Gomez de Liano C, Soberon-Ventura VF, Salcedo-Villanueva G, Santos-Palacios A, Guerrero-Naranjo JL, Fromow-Guerra J, et al. Sensitivity, specificity and predictive values of anterior chamber tap in cases of bacterial endophthalmitis. Eye Vis (Lond). 2017;4:18.CrossRefGoogle Scholar
  11. 11.
    Van der Lelij A, Rothova A. Diagnostic anterior chamber paracentesis in uveitis: a safe procedure? Br J Ophthalmol. 1997;81(11):976–9.CrossRefPubMedPubMedCentralGoogle Scholar
  12. 12.
    Cheung CM, Durrani OM, Murray PI. The safety of anterior chamber paracentesis in patients with uveitis. Br J Ophthalmol. 2004;88(4):582–3.CrossRefPubMedPubMedCentralGoogle Scholar
  13. 13.
    Augsburger JJ. Invasive diagnostic techniques for uveitis and simulating conditions. Trans Pa Acad Ophthalmol Otolaryngol. 1990;42:964–71.PubMedGoogle Scholar
  14. 14.
    Manku H, McCluskey P. Diagnostic vitreous biopsy in patients with uveitis: a useful investigation? Clin Exp Ophthalmol. 2005;33(6):604–10.CrossRefGoogle Scholar
  15. 15.
    Microbiologic factors and visual outcome in the endophthalmitis vitrectomy study. Am J Ophthalmol. 1996;122(6):830–46.Google Scholar
  16. 16.
    Lee EJ, Kim TW, Heo JW, Yu HG, Chung H. Natural killer/T-cell lymphoma of nasal type with intraocular involvement: case report. Eur J Ophthalmol. 2010;20(1):215–7.CrossRefGoogle Scholar
  17. 17.
    Gonzales JA, Chan CC. Biopsy techniques and yields in diagnosing primary intraocular lymphoma. Int Ophthalmol. 2007;27(4):241–50.CrossRefPubMedPubMedCentralGoogle Scholar
  18. 18.
    Chan CC, Buggage RR, Nussenblatt RB. Intraocular lymphoma. Curr Opin Ophthalmol. 2002;13(6):411–8.CrossRefGoogle Scholar
  19. 19.
    Michels RGGW, Engel HM, et al. Diagnostic vitrectomy. In: Jacobiec FASJ, editor. Techniques in ocular surgery. Philadelphia, PA: WB Saunders; 1984.Google Scholar
  20. 20.
    Turno-Krecicka A, Misiuk-Hojlo M, Grzybowski A, Oficjalska-Mlynczak J, Jakubowska-Kopacz M, Jurowska-Liput J. Early vitrectomy and diagnostic testing in severe infectious posterior uveitis and endophthalmitis. Med Sci Monit. 2010;16(6):Cr296–300.PubMedGoogle Scholar
  21. 21.
    Bever GJ, Kim DJ, Afshar AR, Rubenstein JL, Damato BE. Therapeutic vitrectomy as an adjunct treatment to systemic chemotherapy for intraocular lymphoma. Retin Cases Brief Rep. 2017;  https://doi.org/10.1097/ICB.0000000000000668. [Epub ahead of print].
  22. 22.
    Sikic J, Suic SP. Surgical treatment of uveitis. Coll Antropol. 2001;25(Suppl):71–6.PubMedGoogle Scholar
  23. 23.
    Kavanagh MC, Everman KR, Opremcak EM, Foster JA. Uveal melanoma with massive extrascleral extension via pars plana vitrectomy sites. Ophthal Plast Reconstr Surg. 2008;24(4):334–6.CrossRefGoogle Scholar
  24. 24.
    Shen T, Liu R, Lin J, Huang H, Li X, Yan J. Pars plana vitrectomy and evisceration resulting in death due to misdiagnosis of retinoblastoma in children: a review of 3 cases. Medicine. 2015;94(32):e1338.CrossRefPubMedPubMedCentralGoogle Scholar
  25. 25.
    Whitcup SM, de Smet MD, Rubin BI, Palestine AG, Martin DF, Burnier M Jr, et al. Intraocular lymphoma. Clinical and histopathologic diagnosis. Ophthalmology. 1993;100(9):1399–406.CrossRefGoogle Scholar
  26. 26.
    Davis JL, Viciana AL, Ruiz P. Diagnosis of intraocular lymphoma by flow cytometry. Am J Ophthalmol. 1997;124(3):362–72.CrossRefGoogle Scholar
  27. 27.
    Davis JL, Miller DM, Ruiz P. Diagnostic testing of vitrectomy specimens. Am J Ophthalmol. 2005;140(5):822–9.CrossRefGoogle Scholar
  28. 28.
    Blay JY, Burdin N, Rousset F, Lenoir G, Biron P, Philip T, et al. Serum interleukin-10 in non-Hodgkin’s lymphoma: a prognostic factor. Blood. 1993;82(7):2169–74.CrossRefGoogle Scholar
  29. 29.
    Murray PI, Hoekzema R, van Haren MA, de Hon FD, Kijlstra A. Aqueous humor interleukin-6 levels in uveitis. Invest Ophthalmol Vis Sci. 1990;31(5):917–20.PubMedGoogle Scholar
  30. 30.
    Wolf LA, Reed GF, Buggage RR, Nussenblatt RB, Chan CC. Vitreous cytokine levels. Ophthalmology. 2003;110(8):1671–2.CrossRefGoogle Scholar
  31. 31.
    Cassoux N, Giron A, Bodaghi B, Tran TH, Baudet S, Davy F, et al. IL-10 measurement in aqueous humor for screening patients with suspicion of primary intraocular lymphoma. Invest Ophthalmol Vis Sci. 2007;48(7):3253–9.CrossRefPubMedPubMedCentralGoogle Scholar
  32. 32.
    Pulido JS, Salomao DR, Frederick LA, Viswanatha DS. MyD-88 L265P mutations are present in some cases of vitreoretinal lymphoma. Retina (Philadelphia, Pa). 2015;35(4):624–7.CrossRefGoogle Scholar
  33. 33.
    Treon SP, Hunter ZR, Castillo JJ, Merlini G. Waldenstrom macroglobulinemia. Hematol Oncol Clin North Am. 2014;28(5):945–70.CrossRefGoogle Scholar
  34. 34.
    Yeh S, Weichel ED, Faia LJ, Albini TA, Wroblewski KK, Stetler-Stevenson M, et al. 25-gauge transconjunctival sutureless vitrectomy for the diagnosis of intraocular lymphoma. Br J Ophthalmol. 2010;94(5):633–8.CrossRefPubMedPubMedCentralGoogle Scholar
  35. 35.
    Chen RSDJ. Vitreoretinal surgery in inflamed eyes. Retin Physician. 2014;11:40–4.Google Scholar
  36. 36.
    Ranty ML, Laurent C, Aziza J, Mahieu L, Olle P, Quintyn JC, et al. Improving the cytological diagnosis of intraocular lymphoma from vitreous fluid. Histopathology. 2015;67(1):48–61.CrossRefGoogle Scholar
  37. 37.
    Chan CC. Molecular pathology of primary intraocular lymphoma. Trans Am Ophthalmol Soc. 2003;101:275–92.PubMedPubMedCentralGoogle Scholar
  38. 38.
    Peterson K, Gordon KB, Heinemann MH, DeAngelis LM. The clinical spectrum of ocular lymphoma. Cancer. 1993;72(3):843–9.CrossRefGoogle Scholar
  39. 39.
    Whitcup SM, Chan CC, Buggage RR, Nussenblatt RB, Byrnes GA, Rubin BI. Improving the diagnostic yield of vitrectomy for intraocular lymphoma. Arch Ophthalmol. 2000;118(3):446.PubMedGoogle Scholar
  40. 40.
    Malinowski SM. The vitreous trap: a simple, surgeon-controlled technique for obtaining undiluted vitreous and subretinal specimens during pars plana vitrectomy. Retina (Philadelphia, Pa). 2010;30(5):828–9.CrossRefGoogle Scholar
  41. 41.
    Haji MRF. Microincision vitrectomy surgery in infectious endophthalmitis. In: Patelli FRS, editor. Management of complicated vitreoretinal disease. New York, NY: Springer International; 2015. p. 131.Google Scholar
  42. 42.
    Quiroz-Mercado H, Rivera-Sempertegui J, Macky TA, Navarro-Lopez P, Griselda-Alvarez L, Ibarra-Ponce N, et al. Performing vitreous biopsy by perfluorocarbon-perfused vitrectomy. Am J Ophthalmol. 2005;140(6):1161–3.CrossRefGoogle Scholar
  43. 43.
    Rutzen AR, Ortega-Larrocea G, Dugel PU, Chong LP, Lopez PF, Smith RE, et al. Clinicopathologic study of retinal and choroidal biopsies in intraocular inflammation. Am J Ophthalmol. 1995;119(5):597–611.CrossRefGoogle Scholar
  44. 44.
    Johnston RL, Tufail A, Lightman S, Luthert PJ, Pavesio CE, Cooling RJ, et al. Retinal and choroidal biopsies are helpful in unclear uveitis of suspected infectious or malignant origin. Ophthalmology. 2004;111(3):522–8.CrossRefGoogle Scholar
  45. 45.
    Chan CC, Palestine AG, Davis JL, de Smet MD, McLean IW, Burnier M, et al. Role of chorioretinal biopsy in inflammatory eye disease. Ophthalmology. 1991;98(8):1281–6.CrossRefGoogle Scholar
  46. 46.
    Mastropasqua R, Thaung C, Pavesio C, Lightman S, Westcott M, Okhravi N, et al. The role of chorioretinal biopsy in the diagnosis of intraocular lymphoma. Am J Ophthalmol. 2015;160(6):1127–32, e1.CrossRefGoogle Scholar
  47. 47.
    Martin DF, Chan CC, de Smet MD, Palestine AG, Davis JL, Whitcup SM, et al. The role of chorioretinal biopsy in the management of posterior uveitis. Ophthalmology. 1993;100(5):705–14.CrossRefGoogle Scholar
  48. 48.
    Cole CJ, Kwan AS, Laidlaw DA, Aylward GW. A new technique of combined retinal and choroidal biopsy. Br J Ophthalmol. 2008;92(10):1357–60.CrossRefGoogle Scholar
  49. 49.
    Browne AW, Ehlers JP, Sharma S, Srivastava SK. Intraoperative optical coherence tomography-assisted chorioretinal biopsy in the DISCOVER study. Retina (Philadelphia, Pa). 2017;37:2183–7.CrossRefGoogle Scholar

Copyright information

© Springer Nature Singapore Pte Ltd. 2020

Authors and Affiliations

  • Jaya B. Kumar
    • 1
    • 2
  • Sumit Sharma
    • 2
  1. 1.Florida Retina InstituteOrlandoUSA
  2. 2.Ophthalmology, Cole Eye Institute, Cleveland ClinicCleveland Clinic Lerner College of Medicine of Case Western Reserve UniversityClevelandUSA

Personalised recommendations

Cite chapter

Buy options